Exercise and Stress Management Training Prior to Hematopoietic Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902 by Jacobsen, Paul B. et al.
EXERCISE AND STRESS MANAGEMENT TRAINING PRIOR TO
HEMATOPOIETIC CELL TRANSPLANTATION: BLOOD AND
MARROW TRANSPLANT CLINICAL TRIALS NETWORK (BMT
CTN) 0902
Paul B. Jacobsen1, Jennifer Le-Rademacher2, Heather Jim1, Karen Syrjala3, John R.
Wingard4, Brent Logan2, Juan Wu5, Navneet S. Majhail6, William Wood7, J. Douglas Rizzo8,
Nancy L. Geller9, Carrie Kitko10, Edward Faber11, Muneer H. Abidi12, Susan Slater13, Mary
M. Horowitz8, and Stephanie J. Lee3
1Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL
2Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI
3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
4Division of Hematology/Oncology, Department of Medicine, University of Florida College of
Medicine, Gainesville, FL
5The EMMES Corporation, Washington, DC
6Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, OH
7Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel
Hill, NC
8Center for International Blood and Marrow Transplant Research, Department of Medicine,
Medical College of Wisconsin, Milwaukee, WI
9Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, MD
10Pediatric Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI
11Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE
© 2014 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Correspondence: Stephanie J Lee, M.D., M.P.H., Fred Hutchinson Cancer Research Center, D5-290, PO Box 19024, Seattle, WA
98109-1024; Telephone: (206)-667-6190; Fax: (206)-667-1034; sjlee@fhcrc.org.
Prior presentation: American Society of Hematology Annual Meeting, December 2013, New Orleans
Authorship
All authors designed the study, collected and analyzed data, and wrote the paper. JL and BL performed the statistical analysis and
edited the paper. All authors critically revised the manuscript for important intellectual content and approved the manuscript to be
published.
Conflict-of-interest disclosure
The authors declare no competing financial interests related to this study.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Biol Blood Marrow Transplant. Author manuscript; available in PMC 2015 October 01.
Published in final edited form as:






















12Department of Medical Oncology, Wayne State University/Karmanos Cancer Institute
13Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science
University
Abstract
Studies show that engaging patients in exercise and/or stress management techniques during
hematopoietic cell transplantation (HCT) improves quality of life. The Blood and Marrow
Transplant Clinical Trials Network tested the efficacy of training patients to engage in self-
directed exercise and stress management during their HCTs. The study randomized 711 patients at
21 centers to receive one of four training interventions before HCT: a self-directed exercise
program, a self-administered stress management program, both or neither. Participants completed
self-reported assessments at enrollment and up to 180 days after transplant. Randomization was
stratified by center and transplant type. There were no differences in the primary endpoints of the
physical (PCS) and mental (MCS) component scales of the SF36 at day 100 among the groups
based on an intention-to-treat analysis. There were no differences observed in overall survival,
hospital days through day 100 post-HCT, or in other patient-reported outcomes, including
treatment-related distress, sleep quality, pain, and nausea. Patient randomized to training in stress
management reported more use of those techniques; patients randomized to training in exercise
did not report more physical activity. Although other studies have reported efficacy of more
intensive interventions, brief training in an easy-to-disseminate format for either self-directed
exercise or stress management was not effective in our trial.
Keywords
autologous hematopoietic cell transplantation; allogeneic hematopoietic cell transplantation;
exercise; stress management; quality of life
Introduction
The adverse effects of hematopoietic cell transplantation (HCT) on short and long-term
quality of life (QOL) are well documented.1 Patients experience numerous adverse
symptoms such as nausea, fatigue, and sleep disturbance that are accompanied by declines in
physical and mental well-being. Although most longitudinal studies find the majority of
patients return to baseline functioning, it may take years to reach this goal.2–7 Currently,
there are no national guidelines about use of exercise or stress management techniques
during HCT. Transplant centers generally do not have the resources to provide intensive or
ongoing supervision for exercise or stress management techniques to their patients.
Previous single institution studies, including some randomized controlled trials, showed that
engagement in exercise8–25 and stress management26–31 during or after HCT improved
many outcomes in HCT patients. The tested interventions varied from active, guided
sessions to home-based interventions. Outcomes included self-reported measures such as
QOL, mood, fatigue, and distress as well as objective measures of functional status,
strength, stamina, hospital days and survival. In these studies, stress management
interventions primarily improve mental health outcomes and nausea, while relaxation and
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imagery are associated with less pain after HCT.30 The impact of exercise interventions was
more variable; most studies and meta-analyses reported physical health benefits,20,32 while
some studies also reported mental health benefits.24,33 In randomized controlled trials in
patients with solid tumors, stress management training has been shown to improve both
mental and physical health.27 Combining stress management and exercise training is feasible
and well-tolerated by oncology patients,31,34,35 and a recent randomized controlled trial
found that the combination was more effective than usual care in improving anxiety and
depression over the course of outpatient chemotherapy.28
The current study was designed to test whether a brief training session to encourage use of a
self-administered stress management program and/or self-directed exercise program would
improve both physical and mental well-being of autologous and allogeneic patients
following HCT compared to usual care.
Methods
Participants
Patients (n=711) at 21 US centers were enrolled between January 2011–June 2012 through
the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). Inclusion
criteria were: age 18 years or older, ability to speak and read English, ability to exercise at
low to moderate intensity (as judged by self-reported ability to walk up one flight of stairs),
no requirement for supplemental oxygen, and planned autologous or allogeneic HCT within
6 weeks. Exclusion criteria were: orthopedic, neurologic or other problems which prevented
safe ambulation or protocol adherence, participation in another clinical trial with QOL or
functional status as a primary endpoint, planned anti-cancer therapies other than tyrosine
kinase inhibitors or rituximab within 100 days after HCT, planned donor lymphocyte
infusion within 100 days after HCT, and planned tandem transplant.
Study Design
The study was designed as a phase III, randomized, controlled, multicenter trial. After
enrollment and baseline patient self-reported information was collected, patients were
randomized using a factorial design to one of four groups: exercise training, stress
management training, the combination of exercise and stress management training, or usual
care. The intervention was given prior to HCT as a 20-minute introduction to the self-
directed program. Trained site personnel served as the interventionists who reviewed a
pamphlet summarizing the main points of the self-directed program and gave the patients a
DVD reinforcing the program. Patients received a diary in which they could track their
participation in exercise and/or stress management. In addition, the interventionists reviewed
the goals for use of the program, proper technique, identification of barriers to engagement
in exercise or stress management and plans to overcome them. The exercise component also
included calculation of target heart rate and provision of a pedometer. The stress
management component also included provision of a relaxation CD. For all intervention
groups, the interventionists re-contacted patients at 30 and 60 days after HCT to review the
training goals, discuss barriers, and provide encouragement. To ensure fidelity of the
delivered intervention, the first two patient interactions of each interventionist were
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audiotaped and reviewed centrally. Ten percent of subsequent interactions were observed by
another study person at the center to ensure critical material was delivered consistently. All
three intervention groups and the usual care group received a 45 minute DVD of general
information about HCT which included very brief and nonspecific comments about keeping
active and minimizing stress during transplantation.36
The exercise goal was walking 3–5 times a week for at least 20–30 minutes at 50–75% of
estimated heart rate reserve, consistent with guidelines for exercise in cancer patients
developed by the American College of Sports Medicine.37 The stress management goal
targeted paced abdominal breathing,38 progressive muscle relaxation with guided imagery,39
and coping self-statements40 to decrease and manage stress.41
The full protocol is available on the BMT CTN website (www.bmtctn.net). The research
protocol was approved by a protocol review committee appointed by the National Heart,
Lung and Blood Institute (NHLBI), and by local institutional review boards or ethics
committees. All participants provided written informed consent. An NHLBI-appointed Data
and Safety Monitoring Committee provided oversight. This study is registered with
ClinicalTrials.gov, number NCT01278927. All patient materials used in this trial are
available through the Be The Match organization at www.bethematch.org. Readers
interested in additional details of the interventions, including training scripts, should contact
BMT CTN.
Data Collection Instruments
Participants completed self-reported assessments at enrollment and 30, 60, 100 and 180 days
after transplant. Instruments included: (1) Medical Outcomes Study SF36 (SF36), version
2.0, a 36-item, generic multidimensional QOL measure with two summary domains, a
physical component summary (PCS) scale and mental component summary (MCS) scale,
and eight subscales including a 2-item Bodily Pain subscale. The age- and sex-adjusted
norm for the PCS and MCS scales is 50 with a standard deviation of 10 points. Higher
scores indicate better QOL; (2) Cancer and Treatment Distress (CTX-D),7,42 a 27-item
measure of distress with subscales of Uncertainty, Health Burden, Family Strain, Identity,
and Managing the Medical System as well as distress interference with function; (3)
Pittsburgh Sleep Quality Index (PSQI),43–45 a 7-item measure of sleep patterns and
difficulties such as sleep quality, sleep latency, sleep efficiency and use of sleeping
medications; and (4) Nausea, measured by 2 items formatted similar to the SF36 Bodily Pain
subscale. For instruments 2–4, higher scores indicate greater symptom burden. Other
secondary outcomes included hospital days within the first 100 days after graft infusion and
survival.
Measures of adherence were collected to see if patients were engaging in the self-
administered programs. The Leisure Score Index (LSI of the Godin Leisure-Time Exercise
Questionnaire46) was used to measure physical activity.47 Participation in stress
management activities in the past week was measured by a 5-item Stress Reduction
Checklist.27 We also collected participants’ impressions of the perceived program
effectiveness, program importance, and skill of the interventionist on 7-point Likert scales.
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The co-primary endpoints were the SF-36 PCS and MCS at day 100. The study was
designed to have 85% power to detect a clinically meaningful difference of 0.5 standard
deviation (STD) units in the exercise or stress management groups on each of the two
endpoints, maintaining an overall type I error rate of 0.05. The sample size was inflated to
adjust for a 5% failure to undergo HCT, 10% death before day 100, and 15% missing day
100 self-reported data from surviving participants, resulting in a target accrual of 700
patients. Randomization was stratified by center and transplant type (autologous,
myeloablative allogeneic, non-myeloablative allogeneic). Primary analysis was on an
intention-to-treat (ITT) basis that includes all randomized patients classified according to
their assigned treatment. The Exercise groups (exercise only arm and the exercise/stress
management arm) were compared to the No Exercise groups (usual care arm and the stress
management arm). The Stress Management analysis was conducted analogously. Patients
who died within 100 days of transplant were assigned PCS and MCS scores of zero (lower
than the lowest observed score), and those alive at the last follow-up with missing PCS and
MCS were assigned scores of five (lower than the lowest observed score but higher than the
score assigned to patients who died within the first 100 days). Day 100 PCS and MCS were
compared without adjustment for baseline scores or other clinical characteristics using the
Mann-Whitney test, a non-parametric test which only tests the ranks of the scores rather than
the actual scores. Each test was conducted at the 0.025 significance level to adjust for the
co-primary endpoints for each factor.
Secondary analyses examining main effects for PCS and MCS in survivors were conducted
using multiple linear regression adjusting for baseline assessments and other covariates
associated with the outcome. Number of days alive and out of the hospital through day 100
post-HCT and survival within 12 months were compared using the Kruskal-Wallis and log-
rank tests. Three sensitivity analyses for handling missing assessments were conducted for
the day 100 outcomes conditional on being alive: all available data, multiple imputation to
impute missing day 100 values and an inverse probability weighted generalized estimating
equations model to account for missing data.48 Available data for PCS, MCS, pain, sleep
quality, nausea, and cancer and treatment distress at day 100 were evaluated using linear
regression models adjusting for baseline scores. Because of multiple testing, p values <0.01
were considered significant.
Exploratory subgroup analyses were conducted to see if there was a differential treatment
effect on day 100 PCS and MCS scores according to autologous versus myeloablative
allogeneic versus non-myeloablative allogeneic HCT (since this was a stratification factor)
or in groups with high versus low baseline PCS or MCS or high versus low engagement in
exercise and stress management, dichotomized at the median. These analyses adjust for
baseline PCS and MCS scores. Statistical analyses were performed using SAS/STAT
software, version 9.3 (SAS Institute, Inc., Cary, NC).
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The study included 711 participants, evenly distributed between allogeneic and autologous
transplant recipients. Participants were enrolled a median (interquartile range) of 7 (3–13)
days before HCT. The groups were well-balanced for baseline characteristics. (Table 1) At
enrollment, only 2.6% met the American College of Sports Medicine guidelines of 150
minutes of moderate intensity activity per week as measured by the LSI. Approximately
60% of participants had a Karnofsky performance status of 90% or greater. Sixty seven
percent used at least one of the stress management techniques: 53% used self-talk to help
coping, 41% used self-guided relaxation, 34% used deep breathing, 12% listened to
relaxation audiotapes, and 4% watched videos/DVDs about managing stress.
Five (0.7%) patients did not have a transplant, 21 (2.9%) did not have a training session and
two (<0.1%) received the incorrect training. These patients were analyzed with their
assigned groups for the ITT analysis. Additional attrition was due to death and failure to
return surveys (Figure). Survival and missing data rates were similar across study arms. The
primary cause of death within the first six months in all treatment arms was relapse.
Primary endpoint: Day 100 PCS and MCS
There were no differences in the primary endpoints of PCS and MCS at day 100 between the
Exercise and No Exercise groups or between the Stress Management and No Stress
Management groups (all p-values > 0.14, Table 2).
Secondary endpoints - Day 100 and Day 180
Results of analyses conditional on being alive and using only available data or accounting
for missing data by multiple imputation or by inverse probability of censoring weighted
generalized estimating equations48 led to the same conclusion as the primary analyses for
PCS and MCS. There were no differences in day 100 cancer and treatment distress, sleep
quality, pain, and nausea (Table 3) or the SF36 subscales (data not shown). There was no
interaction between the two interventions. No differences were observed in overall survival
at 1 year (p=0.15) or number of days alive and out of the hospital through day 100 post-HCT
(p=0.42). After adjusting for baseline scores, there was no association between assigned
group and day 180 patient-reported outcomes, including PCS, MCS, cancer and treatment
distress, sleep quality, pain, and nausea (data not shown).
Intervention Credibility and Adherence
Participants receiving exercise training thought it would improve their QOL and would want
the training to be available to other patients (p<0.0001), whereas this was not the case with
the stress management training. Training in exercise or stress management had no effect on
self-reported exercise activity at day 30, day 60, and day 100 except physical activity was
higher at day 180 (p = 0.04) in patients assigned to Exercise training after adjusting for
baseline exercise activity. Assignment to Exercise training had no effect on self-reported
stress management activity after adjusting for baseline stress management activity, but
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assignment to Stress Management training was strongly associated with an increase in stress
management activity at all time points (p<0.0003).
Exploratory Analyses
We analyzed predictors of better QOL at day 100 using multiple regression and multiple
imputation for missing values. Higher PCS at day 100 was associated with higher PCS at
enrollment, being employed, and having an autologous transplant rather than a
myeloablative allogeneic HCT or reduced intensity/non-myeloablative allogeneic HCT.
There was no difference between the two types of allogeneic conditioning intensities. Higher
MCS at day 100 was associated with higher MCS at enrollment and higher income (Table
4).
To support future research directions in the HCT population, we explored whether specified
subgroups may have benefited more than others from the training interventions. No benefits
were seen in subgroups of autologous vs. allogeneic groups, lower vs. higher baseline PCS
or MCS scores, or lower vs. higher baseline engagement in exercise or stress management
(data not shown).
Discussion
Despite the fact that meta-analyses of RCTs of exercise and stress management training
suggest benefits for HCT recipients,32,33 our large, multicenter, randomized controlled trial
(RCT) did not show any measurable benefit to a brief training session to encourage patients
to use self-directed exercise or stress management during their HCT. There are a number of
possible explanations for our findings. First, our brief training sessions may have lacked
sufficient intensity to promote adoption of exercise, as we did not see differences at day 30,
60, and 100. Perhaps the peri-transplant time, in the midst of intensive medical preparation
for HCT and the subsequent acute toxicities of HCT, was too intrinsically stressful and
physically limiting to allow patients to benefit from a low intensity, self-administered
exercise program. Similarly, although patients who received stress management training
reported great use of stress management techniques, these strategies may have been
inadequate to ameliorate the negative physical and emotional effects of transplant. A second
possibility is that the self-report measures used in this study were not sufficiently sensitive
to detect intervention effects. One randomized study in HCT patients reported differences in
some objective measures of strength and endurance, but not in self-reported symptoms or
QOL, suggesting that the detected functional differences were not clinically meaningful49 or
that these measures are not reflective of physical functioning.50 The SF-36 PCS and MCS
are global subscales that may not capture improved strength or endurance. However, the
CTXD was developed specifically to measure distress related to HCT, and it has shown
sensitivity to change over the course of treatment.7,42 Measuring the primary outcome at day
100 may have been too early, if physical functioning is dominated by transplant toxicity at
that time, regardless of whether patients were engaging in exercise or stress management.
A third possibility is that broad application of the intervention obscured effects that would
have been observed in some vulnerable or more adherent subgroups. Two trials in HCT
suggested benefits were greatest in the less fit group.14,51 However, we failed to find
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potential beneficiaries in exploratory analyses including those undergoing different types of
transplants or those with more impaired PCS and MCS scores.
It is unlikely that our negative results are due to sufficient participation in exercise and stress
management under usual care, or that patients randomized to usual care benefitted from the
training being delivered to other patients. Although it is common for transplant providers to
encourage patients to stay as active as possible and minimize stress during HCT, exercise
engagement was low in all groups including the usual care group. There was no increase in
use of stress management techniques in patients who did not receive the stress management
training. Some limitations should be noted. We purposefully did not test an intensive guided
exercise or stress management program because many transplant programs do not have the
resources to provide this degree of supervision.52 Studies that provided more intensive
training generally showed more differences,24 although a Cochrane review suggested that a
self-directed component was important to maintain behavior change beyond the intervention
period.53 We also did not collect process information or patient-reported insights to
understand why the training interventions were not successful.
The results of this study suggest several directions for future research on improving QOL
through stress management and exercise training for HCT patients. First, interventions may
be more effective if introduced a sufficient time before transplant to allow patients to
incorporate these practices into their routines, or after transplant when patients have
recovered from short-term treatment side effects, as suggested by our finding showing that
intervention assignment had no effects on exercise activity until day 180. Second, it is also
possible that targeting patients with a demonstrated need for increased exercise (i.e.,
sedentary individuals) or stress management (i.e., distressed individuals) would be more
effective.51,54 Third, the intervention may be more effective if more intensive or
personalized. Internet-based strategies represent one means of increasing the frequency of
contact with participants and tailoring to specific patient needs without the necessity of
adding local professional resources.55,56 Other approaches such as exercise in shorter, more
intensive sessions, supervised group exercise, use of ancillary motivating devices (e.g.,
FitBit, Nike, Jawbone etc) or other forms of exercise (e.g., reclining bicycles) might be more
effective in the HCT population. These methods require more intensive training and follow-
up but may be necessary to achieve change. Given the unexpected results of the present
study, the importance of conducting rigorous evaluations to determine the efficacy of other
potential interventions is clear.
In conclusion, our study does not support a benefit to including a single brief instruction in
exercise or stress management for all HCT recipients to reduce distress or improve physical
or mental functioning during transplant and recovery. While this brief intervention does not
require further testing in our estimation, other methods that might improve physical and
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Table 2
Primary analyses: Intention to treat analysis of Day 100 PCS and MCS





PCS 37.5 (19.7–46.7) 39.7 (27.1–47.7) 0.14
MCS 49.4 (27.3–57.7) 50.1 (34.2–57.8) 0.33
Stress Management (n=356)
Median (25th–75th)
No Stress Management (n=355)
Median (25th–75th)
PCS 37.8 (22.1–46.6) 39.7 (25.7–47.9) 0.21
MCS 50.7 (31.0–58.2) 49.1 (30.5–56.8) 0.30
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